Cita APA

Marcellin, P., Buti Ferret, M., Lim, Y., Chan, H. L. Y., Agarwal, K., & BRUNETTO, M. R. (2024). Eight-year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials.

Citación estilo Chicago

Marcellin, Patrick, Maria Buti Ferret, Young-Suk Lim, Henry Lik Yuen Chan, Kosh Agarwal, y MAURIZIA ROSSANA BRUNETTO. Eight-year Efficacy and Safety of Tenofovir Alafenamide for Treatment of Chronic Hepatitis B Virus Infection: Final Results From Two Randomised Phase 3 Trials. 2024.

Cita MLA

Marcellin, Patrick, et al. Eight-year Efficacy and Safety of Tenofovir Alafenamide for Treatment of Chronic Hepatitis B Virus Infection: Final Results From Two Randomised Phase 3 Trials. 2024.